KPV, the C-terminal tripeptide of -MSH (Lys-Pro-Val), has been investigated for its interaction with NF-B signaling, with researchers observing inhibition of NF-B nuclear translocation and downstream inflammatory cytokine expression (TNF-, IL-6, IL-8) in cell culture models
Administered intramuscularly or subcutaneously, it offers a direct route for replenishing B12 levels, essential for maintaining energy, cognitive function, and overall health
Regulatory standards for supplement manufacturing are less stringent than those for pharmaceuticals, which contributes to contamination and mislabeling
Hormone Replacement Therapy enhances mood and drive
The peptide also promotes polarization of macrophages from pro-inflammatory M1 phenotypes toward tissue-repairing M2 phenotypes, with treated macrophages showing 70% increased phagocytic activity for clearing inflammatory debris and 3-fold higher production of VEGF compared to untreated controls